FeesSafety
Pluang+

Gabelli Global Small and Mid Cap Value Trust declares $0.21/share distribution payable Dec 18, 2026

Company Fundamentals
11 Nov 2026, 20:15 WIB
GlobeNewsWire
View Source
Neutral
Gabelli Global Small and Mid Cap Value Trust declares $0.21/share distribution payable Dec 18, 2026

The Gabelli Global Small and Mid Cap Value Trust announced a quarterly cash distribution of $0.21 per share, payable on December 18, 2026, to shareholders of record as of December 11, 2026. The Fund’s Board of Trustees sets distributions quarterly based on income, capital gains, and market conditions, with potential adjustments in December to meet regulatory requirements. Distributions may include long-term capital gains, qualified dividends, or return of capital, affecting tax treatment for investors. The Fund aims for long-term capital growth by investing primarily in small and mid-cap equities.

The Gabelli Global Small and Mid Cap Value Trust declared a quarterly distribution of $0.21 per share. For readers following US stocks on Pluang, here is the market snapshot as of Nov 12, 2026 00:51 WIB: out of 150 priced US stocks, 87 rose and 60 fell. Notable movers include Roblox Corp (RBLX) at USD 54.08 with a 1-day change of +5.65%, BlackBerry Limited (BB) at USD 9.65 with +5.58%, and Robinhood Markets, Inc. (HOOD) at USD 85.45 with +5.07%.

More News

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...

Market News
Bullish
1 hour ago
Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...

Bullish
1 hour ago
Dylanex offers key Q4 inventory tips for Amazon sellers to avoid stock-outs and manage holiday demand.

Dylanex offers key Q4 inventory tips for Amazon sellers to avoid stock-outs and manage holiday demand.

Dylanex has released practical guidance for Amazon sellers to prepare inventory for the busy Q4 holiday season. The advice focuses on managing inbound shipment timing, avoiding preparation errors, planning around restock limits, and using reserve sto...

Market News
Neutral
4 hours ago
Australia project logistics market to grow to $10.27B by 2031, driven by mining and renewable energy projects

Australia project logistics market to grow to $10.27B by 2031, driven by mining and renewable energy projects

The Australia project logistics market is projected to grow from USD 7.88 billion in 2026 to USD 10.27 billion by 2031, at a CAGR of 5.52%. Growth is fueled by mining and energy projects requiring transport of oversized cargo, and expanding renewable...

Market News
Bullish
4 hours ago
Valens Semiconductor posts modest Q3 gains but ongoing losses and high costs keep sell rating intact

Valens Semiconductor posts modest Q3 gains but ongoing losses and high costs keep sell rating intact

Valens Semiconductor showed some improvement in Q3, driven by a rebound in auto sales. However, expected growth from other industries and AI applications did not materialize, weakening the optimistic outlook. The company continues to face GAAP and EB...

Company Fundamentals
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App